0
Pulmonary Vascular Disease |

Predictors of Outcome in Patients With Pulmonary Hypertension and Heart Failure With Preserved Ejection Fraction

Nadine Al-Naamani*, MD; Stefan Richter, MD; Ioana Preston, MD; Nicholas Hill, MD; Kari Roberts, MD
Author and Funding Information

Tufts Medical Center, Boston, MA


Chest. 2012;142(4_MeetingAbstracts):804A. doi:10.1378/chest.1384104
Text Size: A A A
Published online

Abstract

SESSION TYPE: Pulmonary Hypertension I

PRESENTED ON: Sunday, October 21, 2012 at 10:30 AM - 11:45 AM

PURPOSE: Patients with left sided heart failure with preserved ejection fraction (HFpEF) have elevated pulmonary artery pressures because of increased left-sided filling pressure with normal pulmonary vascular resistance (PVR) or transpulmonary gradient (TPG), WHO Group II, which is the most common form of pulmonary hypertension. A subset of HFpEF patients have elevated PVR and TPG referred to as PH-HFeEF. This study evaluates the predictors of mortality in patients with HFpEF and PH-HFpEF.

METHODS: This is a prospective cohort study of consecutive patients undergoing diagnostic right heart catheterization for suspected pulmonary hypertension at Tufts Medical Center from January 2004 to March 2012. Subjects were included if they had a mPA > 25 and PW > 15 mm Hg. PH-HFpEF was defined as having PVR > 240 dynes.sec.cm-5 and /or TPG > 12 mm Hg. Continuous data were summarized using mean +/- SD and categorical variables summarized with n (%). Survival was assessed using Kaplan-Meier and Cox proportional hazards models.

RESULTS: We identified 51 patients with Group II pulmonary hypertension, of whom 39 patients met the criteria for PH-HFpEF. Patients with PH-HFpEF and HFpEF were similar in terms of age, gender, race, body mass index and cardiac output. The majority of the patients (76%) were classified as New York Heart Association functional class II or III at the time of catheterization. PH-HFpEF was not associated with an increased risk of death (HR 0.49, p 0.36). After adjusting for age and sex, cardiac output and mPA were independently associated with the risk of death (HR 0.51, 1.08; p 0.04 and 0.02, respectively) in all patients with HFpEF and PH-HFpEF.

CONCLUSIONS: In our cohort the presence of PH is not associated with increased risk of death among subjects with HFpEF. Cardiac output was independently associated with better outcomes and mean pulmonary artery pressure was independently associated with worse outcomes.

CLINICAL IMPLICATIONS: Patients with PH-HFpEF did not have worse outcome when compared to patients with HFpEF.

DISCLOSURE: The following authors have nothing to disclose: Nadine Al-Naamani, Stefan Richter, Ioana Preston, Nicholas Hill, Kari Roberts

No Product/Research Disclosure Information

Tufts Medical Center, Boston, MA

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543